Netweb Technologies India Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• One of India's leading Indian origin owned and controlled OEM for HCS with integrated design and manufacturing capabilities.
• Long standing relationship with a marquee and diverse customer base.
• Significant product development and innovation through R&D.
• The Company is one of India's leading HCS provider and it operates in a rapidly evolving and technologically advanced industry with high entry barriers.
• Experienced Board and Senior Management.

• The company success is dependent on its long-term relationship with it Customers. In particular, the company is heavily reliant on its top 10 Customers. The company do not, generally, enter into long term contracts with Customers, which exposes it to risks emanating from the inability to retain its established Customers as the company clients.
• The company derive a majority portion of its revenues from operations from a select few of the company HCS offerings. Loss or decline in the demand of such offerings may result in an adverse effect on its business, revenue from manufacturing operations and financial condition.
• The company depend on few Application Industries for majority of its revenue from operations. Loss of Customers in these Application Industries may result in an adverse effect on its business, revenue from manufacturing operations and financial condition.
• The Company has entered into various non- disclosure agreements with its technology partners to collaborate on design and innovation of products and solutions, most of which are governed by foreign laws. Any failure to comply with the terms of such agreements resulting in breach under such agreements may have monetary implications and cause us reputational harm.
• There are common pursuits between the Company and a member of its Promoter Group. Further, the member of the promoter group provides same products and solutions as it in jurisdictions that are demarcated by a noncompete agreement. Any breach of the non-compete agreement may adversely impact its business operations.

• Expanding and augmenting its product portfolio.
• Expanding geographic footprints in EMEA (i.e., Europe, Middle East and Africa).
• Deepen its penetration across verticals.
• Expanding and augmenting its product portfolio.
• Expanding geographic footprints in EMEA (i.e., Europe, Middle East and Africa).